/
HXBM
$1.79+$0.00 (+0.00%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$1.00 – $6.45
14% from low
Exchange
OTC Link
CS
Price (6 mo)
Loading chart…
Change$-10.42
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2010 | 2011 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $851.7K | $1.9M | $1.8M | $2.4M | $1.8M | $997.7K | $804.2K | $807.2K |
| Cost of revenue | $374.3K | $842.5K | $102.8K | $443.9K | $15.6K | $9.7K | $6.4K | $5.2K |
| Gross profit | $477.4K | $1.0M | $1.7M | $1.9M | $1.7M | $988.0K | $797.8K | $802.0K |
| Gross margin | 56.1% | 55.5% | 94.4% | 81.3% | 99.1% | 99.0% | 99.2% | 99.4% |
| R&D | $748.7K | $501.0K | $1.0M | $1.2M | $892.0K | $317.1K | $510.6K | $176.6K |
| Operating income | −$3.0M | −$2.4M | −$1.2M | −$1.3M | −$1.1M | −$984.1K | −$1.1M | −$595.8K |
| EBITDA | −$2.8M | −$2.3M | −$1.2M | −$995.4K | −$1.2M | −$1.0M | −$975.9K | −$546.3K |
| Net income | −$7.7M | −$2.5M | −$1.9M | −$1.4M | −$1.2M | −$1.1M | −$982.3K | −$551.5K |
| Net margin | -905.4% | -131.6% | -101.0% | -57.3% | -67.9% | -105.8% | -122.1% | -68.3% |
| EPS (diluted) | -85.28 | -15.02 | -9.03 | -6.05 | -5.31 | -4.70 | -4.37 | -2.45 |
Annual figures · source: Financial Modeling Prep
Peer comparison
HELIX BIOMEDIX INC
HELIX BIOMEDIX INC
Held by traders on TradeandTell
No one on the platform currently holds HXBM.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in HXBM as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2013-01-03 | 1-for-300reverse |
Recent trades on TradeandTell
No one on the platform has traded HXBM yet.